"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
A study looking at the side effects of hormone therapy for prostate cancer
This study looked at whether hormone therapy for prostate cancer may increase risk of heart disease and stroke. This trial was supported by Cancer Research UK.
Earlier research had suggested that hormone therapy might lead to body changes that could increase the risk of heart disease, strokes, bone fractures and diabetes. In this study, the researchers used blood tests and scans to look for these changes in men who had started hormone therapy for prostate cancer.
The aim of the study was to learn more about how hormone therapy may affect
Summary of results
The study found that the results of tests for blood pressure, cholesterol, diabetes and bone density did not seem to be affected by hormone therapy for prostate cancer.
45 men took part and had various tests
- Before they started treatment
- After one month of treatment
- After 3 months
- A year later
Some of their test results were different 1 month after starting treatment, but they had returned to normal by the time they had the tests at 3 months.
As this was a small study, the researchers think it is something that needs to be looked at more.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists (
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Malcolm Mason
Cancer Research UK
National Institute for Health Research Cancer Research Network (NCRN)
This is Cancer Research UK trial number CRUK/01/005.